Company Augmedix, Inc.

Equities

AUGX

US05105P1075

Business Support Services

Market Closed - Nasdaq 01:30:00 22/06/2024 am IST 5-day change 1st Jan Change
0.8035 USD +4.22% Intraday chart for Augmedix, Inc. +3.48% -86.26%

Business Summary

Augmedix, Inc. helps clinicians and patients form a human connection at the point of care. The Company uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. It also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.

Number of employees: 1,430

Sales per Business

USD in Million2022Weight2023Weight Delta
Ambient Artificial Intelligence Documentation and Data Solutions
100.0 %
31 100.0 % 45 100.0 % +45.01%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
31 100.0 % 45 100.0 % +45.01%

Managers

Managers TitleAgeSince
Founder 40 01/12/01
Chief Executive Officer 65 01/18/01
Director of Finance/CFO 55 01/20/01
Compliance Officer - 01/16/01
Chief Tech/Sci/R&D Officer - 18/19/18
Chief Tech/Sci/R&D Officer 53 01/20/01
Chief Operating Officer 66 01/19/01
Human Resources Officer - 01/19/01
Corporate Officer/Principal 54 01/19/01

Members of the board

Members of the board TitleAgeSince
Director/Board Member 60 09/22/09
Director/Board Member 60 01/21/01
Director/Board Member 61 10/23/10
Chief Executive Officer 65 01/18/01
Director/Board Member 52 01/17/01
Director/Board Member 55 28/22/28
Founder 40 01/12/01
Chairman 62 28/23/28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 48,967,729 45,884,909 ( 93.70 %) 0 93.70 %

Shareholders

NameEquities%Valuation
Redmile Group LLC
33.54 %
16,421,788 33.54 % 15 M $
Redmile Group LLC
33.45 %
16,380,327 33.45 % 15 M $
Samjo Management LLC
9.762 %
4,780,400 9.762 % 4 M $
Samjo Management LLC
8.085 %
3,959,200 8.085 % 4 M $
Citadel Securities GP LLC
3.858 %
1,889,076 3.858 % 2 M $
Mckesson Ventures LLC
3.211 %
1,572,432 3.211 % 1 M $
Perkins Capital Management, Inc.
2.978 %
1,458,268 2.978 % 1 M $
Cowen Prime Advisors LLC
2.739 %
1,341,000 2.739 % 1 M $
Vanguard Global Advisers LLC
2.660 %
1,302,424 2.660 % 1 M $
Balyasny Asset Management LP
2.412 %
1,180,928 2.412 % 1 M $

Company contact information

Augmedix, Inc.

111 Sutter Street Suite 1300

94104, San Francisco

+

http://www.augmedix.com
address Augmedix, Inc.(AUGX)
  1. Stock Market
  2. Equities
  3. AUGX Stock
  4. Company Augmedix, Inc.